Vaccine Prices
- All
- News
- Videos
-
Why Cervical Cancer Is Dangerous? Experts Explain
As Cervical cancer is the second-leading cause of deaths among women in India is exploring options to cap prices so that the vaccines to treat cervical cancer become more affordable, official sources have said.
-
India Sent Medicine To 150 Countries During Covid Crisis: Health Minister
Union Health Minister Mansukh Mandaviya on Friday said that India sent medicines to 150 countries during covid crisis without increasing the price and compromising on the quality of the medicines.
-
Several Anti-Cancer Drugs, Antibiotics, Now "Essential Medicines", To Be Cheaper
Several anti-cancer drugs, antibiotics and vaccines will now become more affordable as they are among 34 new additions to the National List of Essential Medicines, with the government saying this will reduce "patients' out-of-pocket expenditure".
-
Cervical Cancer: Here's What We Know About The Availability, Price, Etc.
ANI: India's first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price.
-
Cervical Cancer Vaccine, Made In India, To Be Available Soon At Rs 200-400
India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in theaffordable price range of Rs 200-400.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
At UN, India's Covid Vaccine Swipe At West As It Defends Wheat Export Ban
Voicing concern over the hoarding of food grains and discrimination amid the "unjustified increase" in food prices, the government on Wednesday said that the issue should not go the way of Covid-19 vaccines.
-
Biological E's Corbevax Price Cut To Rs 250 Per Dose For Private Centres
Pharmaceuticals firm Biological E today said it has reduced the price of its COVID-19 vaccine Corbevax to Rs 250 from Rs 840 a dose, inclusive of goods and services tax, for private vaccination centres.
-
Private Hospitals In Delhi, Tamil Nadu Yet To Slash Covid Vaccine Prices
Private hospitals in Tamil Nadu have not slashed the prices of Covid vaccines -- Covishield ad Covaxin -- even though the government has announced a massive reduction.
-
Centre Allows Private Centres To Charge Up To Rs 150 Above Vaccine Price
Centre has told the states that the precaution dose will be of the same COVID-19 vaccine as the one used for the administration of the first two doses. Private vaccine centres can charge Rs 150 per dose as service charge above the cost of vaccine.
-
Coronavirus Highlights: Covishield, Covaxin Prices Cut To Rs 225
The prices of Covishield and Covaxin vaccines at private hospitals have been slashed by more than half. This comes a day before the Covid vaccine booster shots become available to all Indian adults.
-
Oil Prices Plunge As Omicron's Rapid Spread Dims Fuel Demand Outlook
Oil prices fell despite Moderna Inc's announcement on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against Omicron in laboratory testing.
-
"Price I'm Willing To Pay": Novak Djokovic Picks Vaccine Stance Over Tournaments
Tennis superstar Novak Djokovic has said that he is willing to not take part in tournaments if he is asked to be vaccinated
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Can't Afford Price Of Laxity Of Not Vaccinating People: Supreme Court
The Supreme Court on Friday said it cannot just cast doubt on the country's Covid vaccination programme at this crucial stage and cannot afford the price of laxity of not vaccinating people.
-
Why Cervical Cancer Is Dangerous? Experts Explain
As Cervical cancer is the second-leading cause of deaths among women in India is exploring options to cap prices so that the vaccines to treat cervical cancer become more affordable, official sources have said.
-
India Sent Medicine To 150 Countries During Covid Crisis: Health Minister
Union Health Minister Mansukh Mandaviya on Friday said that India sent medicines to 150 countries during covid crisis without increasing the price and compromising on the quality of the medicines.
-
Several Anti-Cancer Drugs, Antibiotics, Now "Essential Medicines", To Be Cheaper
Several anti-cancer drugs, antibiotics and vaccines will now become more affordable as they are among 34 new additions to the National List of Essential Medicines, with the government saying this will reduce "patients' out-of-pocket expenditure".
-
Cervical Cancer: Here's What We Know About The Availability, Price, Etc.
ANI: India's first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price.
-
Cervical Cancer Vaccine, Made In India, To Be Available Soon At Rs 200-400
India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in theaffordable price range of Rs 200-400.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
At UN, India's Covid Vaccine Swipe At West As It Defends Wheat Export Ban
Voicing concern over the hoarding of food grains and discrimination amid the "unjustified increase" in food prices, the government on Wednesday said that the issue should not go the way of Covid-19 vaccines.
-
Biological E's Corbevax Price Cut To Rs 250 Per Dose For Private Centres
Pharmaceuticals firm Biological E today said it has reduced the price of its COVID-19 vaccine Corbevax to Rs 250 from Rs 840 a dose, inclusive of goods and services tax, for private vaccination centres.
-
Private Hospitals In Delhi, Tamil Nadu Yet To Slash Covid Vaccine Prices
Private hospitals in Tamil Nadu have not slashed the prices of Covid vaccines -- Covishield ad Covaxin -- even though the government has announced a massive reduction.
-
Centre Allows Private Centres To Charge Up To Rs 150 Above Vaccine Price
Centre has told the states that the precaution dose will be of the same COVID-19 vaccine as the one used for the administration of the first two doses. Private vaccine centres can charge Rs 150 per dose as service charge above the cost of vaccine.
-
Coronavirus Highlights: Covishield, Covaxin Prices Cut To Rs 225
The prices of Covishield and Covaxin vaccines at private hospitals have been slashed by more than half. This comes a day before the Covid vaccine booster shots become available to all Indian adults.
-
Oil Prices Plunge As Omicron's Rapid Spread Dims Fuel Demand Outlook
Oil prices fell despite Moderna Inc's announcement on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against Omicron in laboratory testing.
-
"Price I'm Willing To Pay": Novak Djokovic Picks Vaccine Stance Over Tournaments
Tennis superstar Novak Djokovic has said that he is willing to not take part in tournaments if he is asked to be vaccinated
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Can't Afford Price Of Laxity Of Not Vaccinating People: Supreme Court
The Supreme Court on Friday said it cannot just cast doubt on the country's Covid vaccination programme at this crucial stage and cannot afford the price of laxity of not vaccinating people.
